739
Citations
308
Journals
2020
First Cited
2022
Last Cited

Articles citing This Document (Page 1 of 15)

ArticleJournalYear
Recent advances in the vaccine development for the prophylaxis of SARS Covid-192022
Selective reversed-phase high-performance liquid chromatography method for the determination of intact SARS-CoV-2 spike protein2022
Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design2022
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses2022
SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study2022
Differential immune response induced by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
Interventions to increase COVID-19 vaccine uptake: a scoping review2022
Breakthrough COVID-19 infection according to the infectious diseases hospital2022
Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study2022
Evaluation of response to different COVID‐19 vaccines in vaccinated healthcare workers in a single center in Iran
Safety and Immunogenicity of a Recombinant Protein RBD Fusion Heterodimer Vaccine against SARS-CoV-2: preliminary results of a phase 1-2a dose-escalating, randomized, double-blind clinical trial
Development of virus‐like particles‐based vaccines against coronaviruses
Think like a Virus: Toward Improving Nanovaccine Development against SARS-CoV-22022
Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview
An in silico approach to study the role of epitope order in the multi-epitope-based peptide (MEBP) vaccine design2022
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast2022
Protective Effect of Inactivated COVID-19 Vaccines against Progression of SARS-CoV-2 Omicron and Delta Variant Infections to Pneumonia in Beijing, China, in 20222022
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-22022
Aşılama Sürecinden Hemen Önce Dijital Medyada COVID-19 Aşıları ile İlgili Haberlerin İçerik Analizi
Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet lightArchives of Virology
Three-Dimensional Visualization of Viral Structure, Entry, and Replication Underlying the Spread of SARS-CoV-2Chemical Reviews
Current Updates on COVID-19 Vaccines and Therapeutics: As of June 2022Biotechnology and Bioprocess Engineering
Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in ChinaExpert Review of Vaccines
Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approachesVirus Research2022
Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized studyVaccine: X2022
Vaccine-induced immune thrombotic thrombocytopenia presenting as a mimic of heparin-induced thrombocytopenia in a hemodialysis patient receiving ChAdOx1 nCoV-19 vaccineRenal Failure2022
Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected PatientsVaccines2022
Attitudes to Vaccine Mandates among Late Adopters of COVID-19 Vaccines in ZimbabweVaccines2022
EVALUATION OF ADENOVIRAL VECTOR-BASED VACCINES FOR PREVENTION OF COVID-19 – AN OVERVIEWAsian Journal of Pharmaceutical and Clinical Research
Differential symptoms among COVID-19 outpatients before and during periods of SARS-CoV-2 Omicron variant dominance in Blantyre, Malawi: a prospective observational study
Viral Vector Vaccine Development and Application during the COVID-19 PandemicMicroorganisms2022
Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individualsBMC Infectious Diseases2022
Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humansScientific Reports2022
Safety and Immunogenicity of Inactivated Bacillus subtilis Spores as a Heterologous Antibody Booster for COVID-19 VaccinesVaccines2022
Analysis of global COVID-19 vaccine policies with public value mapping approachBalıkesir Üniversitesi Sosyal Bilimler Enstitüsü Dergisi
Predictors of COVID-19 Stress and COVID-19 Vaccination Acceptance among Adolescents in GhanaInternational Journal of Environmental Research and Public Health2022
COVID-19 vaccine hesitancy and acceptance among the public in the Gulf Cooperation Council countries: A review of the literatureHuman Vaccines and Immunotherapeutics
COVID-19 vaccine breakthrough infections among fully vaccinated Health Care Workers in Lagos, Nigeria
Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case studyPathogens and Global Health
Pediatrik COVID-19 Enfeksiyonu ve Hemşirelik Yaklaşımı: Güncel Gelişmeler
One year of COVID-19 vaccination2022
Structural basis of Omicron immune evasion: A comparative computational studyComputers in Biology and Medicine2022
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trialsVaccine2022
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistanceNature Communications2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsHuman Vaccines and Immunotherapeutics
Characterization of nanoparticles-based vaccines for COVID-19Nature Nanotechnology2022
Safety and Efficacy of COVID‐19 Vaccines in Children and Adolescents: a Systematic Review of Randomized Controlled TrialsJournal of Medical Virology
A national survey of COVID-19 vaccine acceptance in NigeriaVaccine2022
Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory ProteinsInternational Journal of Molecular Sciences2022
SARS-CoV-2: phenotype, genotype, and characterization of different variantsCellular and Molecular Biology Letters2022